Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
NanoView Biosciences is a life sciences company revolutionizing the way researchers study exosomes and other extracellular vesicles (EVs). Their proprietary ExoView® platform provides high-throughput, label-free analysis of individual EVs, enabling direct measurement of their size, count, and biomarker colocalization. This technology empowers scientists in fields like diagnostics, therapeutics, and basic research to unlock the potential of EVs for understanding and combating diseases such as cancer, neurodegenerative disorders, and infectious diseases. NanoView aims to accelerate scientific discovery and the development of new clinical applications by providing robust and easy-to-use tools for comprehensive EV characterization.
The Boston headquarters serves as the central hub for research and development, manufacturing of their ExoView platform and consumables, corporate leadership, sales, marketing, and customer support operations.
Located in a modern facility within Boston's Seaport Innovation District, designed to support advanced biotechnology research, development, and manufacturing with state-of-the-art laboratory spaces.
The work culture at NanoView Biosciences emphasizes innovation, collaboration, scientific excellence, and a customer-centric approach. Employees are driven by the mission to advance biological understanding and improve human health.
The Boston location provides access to a rich ecosystem of leading academic institutions, research hospitals, pharmaceutical companies, and a highly skilled talent pool, fostering collaborations and innovation.
While NanoView Biosciences's primary operations and headquarters are in Boston, USA, the company supports a global customer base through direct sales and a network of international distributors. Their instruments and consumables are utilized by researchers in academic institutions, biotech, and pharmaceutical companies worldwide. This global reach facilitates the adoption of their ExoView technology for exosome research across various continents.
21 Drydock Avenue, Suite 610W
Boston
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NanoView Biosciences' leadership includes:
NanoView Biosciences has been backed by several prominent investors over the years, including:
In the past year, NanoView Biosciences notably appointed Jerry Williamson as its new CEO to drive its next phase of growth. No other major public announcements regarding executive exits were readily found.
Discover the tools NanoView Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NanoView Biosciences likely uses common corporate email formats. The most probable format is the first initial followed by the last name.
[first_initial][last]@nanoviewbio.com
Format
jwilliamson@nanoviewbio.com
Example
80%
Success rate
Business Wire • April 16, 2024
NanoView Biosciences announced the launch of its Nanoparticle Tracking Analysis (NTA)-based sizing module for the ExoView R200 platform. This addition allows for orthogonal EV sizing, complementing the platform's single-vesicle imaging and biomarker analysis capabilities....more
Business Wire • June 7, 2023
NanoView Biosciences announced the appointment of Jerry Williamson as its new Chief Executive Officer. Williamson brings over 25 years of experience in the life sciences industry to lead NanoView's next phase of growth....more
PR Newswire • May 17, 2021
NanoView Biosciences announced the closing of a $17 million Series C financing round. The funding was led by Northpond Ventures, with participation from existing and new investors including Sands Capital and OSF Ventures. The funds will be used to scale commercialization of the ExoView platform and expand research capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NanoView Biosciences, are just a search away.